Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Director Dealing

2 Apr 2015 07:00

RNS Number : 2552J
PuriCore Plc
02 April 2015
 



PuriCore plc ("PuriCore" or the "Company")

 

Director Dealing

 

2 April 2015 - PuriCore plc (AIM: PURI), an international company focused on safe and effective protection against the spread of infectious pathogens, today announces a director dealing, in accordance with the Disclosure and Transparency Rules. On 1 April 2015, the following Director notified the Company that he had purchased ordinary shares of 10p each in the share capital of the Company ("Shares"), as set out below.

 

 

 

Name

Date purchased

Number of Shares purchased

Purchase price of Shares

Shareholding following the acquisition

% of issued share capital

Charles SpicerNon-Executive Chairman

1 Apr 2014

 

50,610

 

32p

 

75,000

 

0.15%

 

 

-Ends-

 

Enquiries:

 

PuriCore plc

+44 (0) 20 3727 1000

Michael Ashton, Chief Executive Officer

Marella Thorell, Chief Financial Officer and Chief Operating Officer

FTI Consulting

+44 (0) 20 3727 1000

Simon Conway / Mo Noonan / Victoria Foster Mitchell

N+1 Singer (Nominated Adviser & Broker)

+44 (0) 20 7496 3000

Aubrey Powell / Jen Boorer / Thomas Smale

 

 

About PuriCore

PuriCore is an international company focused on developing and commercialising safe and effective products to protect against the spread of infectious pathogens based on its proprietary hypochlorous acid platform technology. Its products are currently used in two broad market segments: Supermarket Retail and Health Sciences. PuriCore's products do not cause harm to human or animal life or to the environment.

 

In the Supermarket Retail segment, PuriCore offers products to US retailers for use in their fresh produce departments to improve food safety and quality, to extend shelf life and to decrease food wastage. Our product is an eco-friendly, food-safe sanitising solution at a neutral PH that is used to protect produce from cross contamination and improve freshness. Our Sterilox Fresh Systems are capital equipment that are installed at customer locations and allow for generation of solution as needed at the store. ProduceFresh is our concentrate bottled version providing the same levels of stability, freshness and quality in a convenient consumable package. Additionally, the Company's FloraFresh products, also sold as a concentrate in bottled form, protect against fungal growth and extend the life of cut flowers, with an initial focus on supermarket floral departments.

 

In Health Sciences, PuriCore's Wound Care business provides products that are used to treat chronic and acute wounds, including diabetic ulcers and burns in humans. A range of products have also been developed to manage wounds in companion and farm animals. The Company's Dermatology business is currently focused on treatments for atopic dermatitis. PuriCore is headquartered in Malvern, Pennsylvania.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUGUQGCUPAPPG
Date   Source Headline
2nd Nov 20097:00 amRNSDarren Weiss promoted to CFO & Executive Director
15th Sep 20099:47 amRNSHolding(s) in Company
2nd Sep 20092:32 pmRNSHolding(s) in Company
27th Aug 20097:00 amRNSTotal Voting Rights
25th Aug 20094:18 pmRNSHolding(s) in Company
25th Aug 20097:00 amRNSPuriCore New $2.1 Million Facility
25th Aug 20097:00 amRNSInterim Results
5th Aug 20097:00 amRNSTrading Statement
5th Aug 20097:00 amRNSAcquisition and Placing
4th Aug 20097:00 amRNSBlocklisting Interim Review
24th Jul 20094:40 pmRNSSecond Price Monitoring Extn
24th Jul 20094:35 pmRNSPrice Monitoring Extension
10th Jul 20094:40 pmRNSSecond Price Monitoring Extn
10th Jul 20094:35 pmRNSPrice Monitoring Extension
7th Jul 20094:40 pmRNSSecond Price Monitoring Extn
7th Jul 20094:35 pmRNSPrice Monitoring Extension
17th Jun 20097:00 amRNSPresenting at Piper Jaffray European Conference
5th Jun 200911:20 amRNSResult of AGM
28th May 20091:16 pmRNSUS retailer extends use of Sterilox systems
27th May 20097:00 amRNSAnnual Information Update
30th Apr 20095:01 pmRNSHolding(s) in Company
30th Apr 20097:00 amRNSSterilox Effective against Human/Animal Influenza
28th Apr 20097:01 amRNSQ1 Interim Management Statement
28th Apr 20097:00 amRNSFinal Results
17th Feb 200910:45 amRNSHolding(s) in Company
10th Feb 20094:28 pmRNSDirector/PDMR Shareholding
9th Feb 20097:00 amRNSDirector/PDMR Shareholding
6th Feb 200910:27 amRNSHolding(s) in Company
4th Feb 20099:28 amRNSBlocklisting Interim Review
3rd Feb 20099:41 amRNSDirector/PDMR Shareholding
2nd Feb 20097:00 amRNSTrading Statement
2nd Jan 20097:00 amRNSDirector/PDMR Shareholding
29th Dec 20084:34 pmRNSDirector/PDMR Shareholding
19th Dec 20084:43 pmRNSSecond Price Monitoring Extn
19th Dec 20084:36 pmRNSPrice Monitoring Extension
12th Nov 20085:01 pmRNSDirector/PDMR Shareholding
3rd Nov 20087:00 amRNSNotification of PDMR Interest - Option Award
24th Oct 20087:00 amRNSReceives an order from Safeway
13th Oct 20087:01 amRNSBoard and Organisational Changes
13th Oct 20087:00 amRNSInterim Management Statement
1st Oct 20087:00 amRNSRaises $9.74 million
11th Sep 20085:51 pmRNSHolding(s) in Company
4th Sep 20085:51 pmRNSHolding(s) in Company
3rd Sep 20085:26 pmRNSHolding(s) in Company
29th Aug 20082:44 pmRNSPDMR Dealings
29th Aug 20087:00 amRNSTotal Voting Rights
29th Aug 20087:00 amRNSInterim Results
26th Aug 20083:02 pmRNSResult of General Meeting
22nd Aug 20087:00 amRNSResult of Open Offer
4th Aug 20088:27 amRNSBlocklisting six monthly retu

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.